FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NovaBay Pharmaceuticals's Free Cash Flow for the
three
months ended in Dec. 2023 was $-0.32 Mil. NovaBay Pharmaceuticals's Revenue for the
three
months ended in Dec. 2023 was $3.73 Mil. Therefore, NovaBay Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was -8.48%.
As of today, NovaBay Pharmaceuticals's current FCF Yield % is -148.75%.
The historical rank and industry rank for NovaBay Pharmaceuticals's FCF Margin % or its related term are showing as below:
NBY'
s FCF Margin % Range Over the Past 10 Years
Min: -1434.82 Med: -69.19 Max: -28.18
Current: -28.18
During the past 13 years, the highest FCF Margin % of NovaBay Pharmaceuticals was -28.18%. The lowest was -1434.82%. And the median was -69.19%.
NBY's FCF Margin % is ranked better than 67.41% of 1031
companies
in the Biotechnology industry
Industry Median: -148.24
vs NBY: -28.18
NovaBay Pharmaceuticals FCF Margin % Historical Data
The historical data trend for NovaBay Pharmaceuticals's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NovaBay Pharmaceuticals's FCF Margin %
For the Biotechnology subindustry, NovaBay Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovaBay Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NovaBay Pharmaceuticals's FCF Margin % distribution charts can be found below:
* The bar in red indicates where NovaBay Pharmaceuticals's FCF Margin % falls into.
NovaBay Pharmaceuticals FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
NovaBay Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovaBay Pharmaceuticals FCF Margin % Related Terms
Thank you for viewing the detailed overview of NovaBay Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
NovaBay Pharmaceuticals (NovaBay Pharmaceuticals) Business Description
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NBY has been successfully added to your 